Hypofractionated vs. Twice Daily Radiotherapy for Limited Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis

被引：0
作者：
Zhao, L. [1 ]
Zhou, W. [1 ]
Yin, Y. [1 ]
Shi, M. [1 ]
机构：
[1] Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2974
引用
收藏
页码：E470 / E470
页数：1
相关论文
共 50 条
  • [41] Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (LS-SCLC) with daily fractionation: A national cancer database (NCDB) propensity matched analysis
    White, R.
    Hasan, S.
    Renz, P.
    Abel, S.
    Otaibi, Z.
    Colonias, A.
    Monga, D.
    Wegner, R. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 247 - 248
  • [42] Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis
    Inoue, Yuko
    Tsujino, Kayoko
    Sulaiman, Nor Shazrina
    Marudai, Mitsuru
    Kajihara, Akifumi
    Miyazaki, Shuichiro
    Sekii, Shuhei
    Uezono, Haruka
    Ota, Yousuke
    Soejima, Toshinori
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (05) : 877 - 883
  • [43] Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes
    John M. Watkins
    John A. Fortney
    Amy E. Wahlquist
    Keisuke Shirai
    Elizabeth Garrett-Mayer
    Eric G. Aguero
    Carol A. Sherman
    Andrew T. Turrisi
    Anand K. Sharma
    Japanese Journal of Radiology, 2010, 28 : 340 - 348
  • [44] Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer
    Yee, Don
    Halperin, Ross
    Hanson, John
    Nijjar, Tirath
    Butts, Charles
    Smylie, Michael
    Reiman, Tony
    Roa, Wilson
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (02): : 466 - 473
  • [45] A Strategy to Reduce Acute Toxicity from Twice Daily Chemoradiation Therapy for Limited-Stage Small-Cell Lung Cancer
    Xanthopoulos, E. P.
    Corradetti, M. N.
    Grover, S.
    Heilbroner, S. P.
    Cheng, S. K.
    Simone, C. B., II
    Rengan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E503 - E503
  • [46] Left Upper Lobectomy vs Trisegmentectomy for Lung Cancer: A Propensity Score-Matched Comparison
    Mcallister, Miles A.
    Herrera-Zamora, Julio
    Barcelos, Rafael R.
    Leo, Rachel
    Sugarbaker, Evert A.
    Singh, Anupama
    Mazzola, Emanuele
    Figueroa, Paula A. Ugalde
    Jaklitsch, Michael T.
    Swanson, Scott J.
    ANNALS OF THORACIC SURGERY, 2025, 119 (04) : 786 - 795
  • [47] The diagnosis of limited stage small-cell lung cancer
    Sas-Korczynska, Beata
    Wojcik, Ewa
    Luczynska, Elzbieta
    Kulpa, Jan
    Korzeniowski, Stanislaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2008, 12 (01): : 1 - 5
  • [48] Facility-Level Analysis of Twice Daily Radiation Utilization for Limited Stage Small Cell Lung Cancer
    Tsekouras, I. T.
    Hotsinpiller, W. S.
    Bonner, J. A.
    Kole, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E67 - E67
  • [49] Which fractionation of radiotherapy is best for limited-stage small-cell lung cancer?
    Fietkau, Rainer
    LANCET ONCOLOGY, 2017, 18 (08) : 994 - 995
  • [50] Involved-field radiotherapy in limited-stage small-cell lung cancer
    C-R Chien
    C-J Yu
    British Journal of Cancer, 2007, 97 : 275 - 275
12345